133 related articles for article (PubMed ID: 30066986)
1. COX Inhibition Profiles and Molecular Docking Studies of the Lignan Hinokinin and Some Synthetic Derivatives.
Borges A; Casoti R; E Silva MLA; da Cunha NL; da Rocha Pissurno AP; Kawano DF; da Silva de Laurentiz R
Mol Inform; 2018 Dec; 37(12):e1800037. PubMed ID: 30066986
[TBL] [Abstract][Full Text] [Related]
2. In vivo and in silico anti-inflammatory mechanism of action of the semisynthetic (-)-cubebin derivatives (-)-hinokinin and (-)-O-benzylcubebin.
Lima TC; Lucarini R; Volpe AC; de Andrade CQJ; Souza AMP; Pauletti PM; Januário AH; Símaro GV; Bastos JK; Cunha WR; Borges A; da Silva Laurentiz R; Conforti VA; Parreira RLT; Borges CHG; Caramori GF; Andriani KF; E Silva MLA
Bioorg Med Chem Lett; 2017 Jan; 27(2):176-179. PubMed ID: 27955811
[TBL] [Abstract][Full Text] [Related]
3. Sulfonamido, azidosulfonyl and N-acetylsulfonamido analogues of rofecoxib: 4-[4-(N-acetylsulfonamido)phenyl]-3-(4-methanesulfonylphenyl)-2(5H)furanone is a potent and selective cyclooxygenase-2 inhibitor.
Zarghi A; Praveen Rao PN; Knaus EE
Bioorg Med Chem Lett; 2004 Apr; 14(8):1957-60. PubMed ID: 15050636
[TBL] [Abstract][Full Text] [Related]
4. Trypanocidal activity of (-)-cubebin derivatives against free amastigote forms of Trypanosoma cruzi.
de Souza VA; da Silva R; Pereira AC; Royo Vde A; Saraiva J; Montanheiro M; de Souza GH; da Silva Filho AA; Grando MD; Donate PM; Bastos JK; Albuquerque S; e Silva ML
Bioorg Med Chem Lett; 2005 Jan; 15(2):303-7. PubMed ID: 15603944
[TBL] [Abstract][Full Text] [Related]
5. In Vitro and In Silico Evaluation of New 1,3,4-Oxadiazole Derivatives of Pyrrolo[3,4-
Peregrym K; Szczukowski Ł; Wiatrak B; Potyrak K; Czyżnikowska Ż; Świątek P
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502040
[TBL] [Abstract][Full Text] [Related]
6. COX Inhibition Profile and Molecular Docking Studies of Some 2-(Trimethoxyphenyl)-Thiazoles.
Oniga SD; Pacureanu L; Stoica CI; Palage MD; Crăciun A; Rusu LR; Crisan EL; Araniciu C
Molecules; 2017 Sep; 22(9):. PubMed ID: 28891941
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, anti-inflammatory, analgesic and COX-1/2 inhibition activities of anilides based on 5,5-diphenylimidazolidine-2,4-dione scaffold: Molecular docking studies.
Abdel-Aziz AA; El-Azab AS; Abou-Zeid LA; ElTahir KE; Abdel-Aziz NI; Ayyad RR; Al-Obaid AM
Eur J Med Chem; 2016 Jun; 115():121-31. PubMed ID: 26999325
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel pyrazole and pyrazolo[1,5-a]pyrimidine derivatives as cyclooxygenase inhibitors (COX-1 and COX-2) using molecular modeling simulation.
Ayman R; Radwan AM; Elmetwally AM; Ammar YA; Ragab A
Arch Pharm (Weinheim); 2023 Feb; 356(2):e2200395. PubMed ID: 36336646
[TBL] [Abstract][Full Text] [Related]
9. Detailed 1H and 13C NMR structural assignment of three biologically active lignan lactones.
Heleno VC; da Silva R; Pedersoli S; de Albuquerque S; Bastos JK; Silva ML; Donate PM; da Silva GV; Lopes JL
Spectrochim Acta A Mol Biomol Spectrosc; 2006 Jan; 63(1):234-9. PubMed ID: 16344252
[TBL] [Abstract][Full Text] [Related]
10. Benzodioxole-Pyrazole Hybrids as Anti-Inflammatory and Analgesic Agents with COX-1,2/5-LOX Inhibition and Antioxidant Potential.
Abd El Razik HA; Badr MH; Atta AH; Mouneir SM; Abu-Serie MM
Arch Pharm (Weinheim); 2017 May; 350(5):. PubMed ID: 28418202
[TBL] [Abstract][Full Text] [Related]
11. Toward the understanding of the molecular basis for the inhibition of COX-1 and COX-2 by phenolic compounds present in Uruguayan propolis and grape pomace.
Paulino M; Alvareda E; Iribarne F; Miranda P; Espinosa V; Aguilera S; Pardo H
J Biomol Struct Dyn; 2016 Dec; 34(12):2643-2657. PubMed ID: 26610257
[TBL] [Abstract][Full Text] [Related]
12. Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.
Chan CC; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Ford-Hutchinson AW; Forrest MJ; Gauthier JY; Gordon R; Gresser M; Guay J; Kargman S; Kennedy B; Leblanc Y; Leger S; Mancini J; O'Neill GP; Ouellet M; Patrick D; Percival MD; Perrier H; Prasit P; Rodger I
J Pharmacol Exp Ther; 1999 Aug; 290(2):551-60. PubMed ID: 10411562
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of new water-soluble tetrazolide derivatives of celecoxib and rofecoxib as selective cyclooxygenase-2 (COX-2) inhibitors.
Navidpour L; Amini M; Shafaroodi H; Abdi K; Ghahremani MH; Dehpour AR; Shafiee A
Bioorg Med Chem Lett; 2006 Sep; 16(17):4483-7. PubMed ID: 16806914
[TBL] [Abstract][Full Text] [Related]
14. Thiazole derivatives as inhibitors of cyclooxygenases in vitro and in vivo.
El-Achkar GA; Jouni M; Mrad MF; Hirz T; El Hachem N; Khalaf A; Hammoud S; Fayyad-Kazan H; Eid AA; Badran B; Merhi RA; Hachem A; Hamade E; Habib A
Eur J Pharmacol; 2015 Mar; 750():66-73. PubMed ID: 25617797
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship of celecoxib and rofecoxib for the membrane permeabilizing activity.
Yamakawa N; Suzuki K; Yamashita Y; Katsu T; Hanaya K; Shoji M; Sugai T; Mizushima T
Bioorg Med Chem; 2014 Apr; 22(8):2529-34. PubMed ID: 24650702
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, anti-inflammatory screening, molecular docking, and COX-1,2/-5-LOX inhibition profile of some novel quinoline derivatives.
Chaaban I; Rizk OH; Ibrahim TM; Henen SS; El-Khawass EM; Bayad AE; El-Ashmawy IM; Nematalla HA
Bioorg Chem; 2018 Aug; 78():220-235. PubMed ID: 29602046
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo activity of lignan lactones derivatives against Trypanosoma cruzi.
Saraiva J; Vega C; Rolon M; da Silva R; E Silva ML; Donate PM; Bastos JK; Gomez-Barrio A; de Albuquerque S
Parasitol Res; 2007 Mar; 100(4):791-5. PubMed ID: 17053932
[TBL] [Abstract][Full Text] [Related]
18. Antileukemic activity of lignans and phenylpropanoids of Cinnamomum parthenoxylon.
Adfa M; Rahmad R; Ninomiya M; Yudha S S; Tanaka K; Koketsu M
Bioorg Med Chem Lett; 2016 Feb; 26(3):761-764. PubMed ID: 26774581
[TBL] [Abstract][Full Text] [Related]
19. Biotransformation of (-)-cubebin by
Arruda C; Eugênio DS; Moreira MR; Símaro GV; Bastos JK; Martins CHG; Silva MLA; Veneziani RCS; Vieira PB; Ambrósio SR
Nat Prod Res; 2018 Dec; 32(23):2803-2816. PubMed ID: 28982254
[TBL] [Abstract][Full Text] [Related]
20. Oxicams bind in a novel mode to the cyclooxygenase active site via a two-water-mediated H-bonding Network.
Xu S; Hermanson DJ; Banerjee S; Ghebreselasie K; Clayton GM; Garavito RM; Marnett LJ
J Biol Chem; 2014 Mar; 289(10):6799-6808. PubMed ID: 24425867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
